Overview
- Brings together the fundamental theory and practice of controlled release drug delivery to the airways
- Serves as both a reference text and a toolbox for translating our fundamental understanding into practical approaches
- Provides a sound background on the biological barriers and opportunities for controlled release pulmonary drug delivery
- Includes supplementary material: sn.pub/extras
Part of the book series: Advances in Delivery Science and Technology (ADST)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (22 chapters)
-
Front Matter
Keywords
About this book
The pace of new research and level of innovation repeatedly introduced into the field of drug delivery to the lung is surprising given its state of maturity since the introduction of the pressurized metered dose inhaler over a half a century ago. It is clear that our understanding of pulmonary drug delivery has now evolved to the point that inhalation aerosols can be controlled both spatially and temporally to optimize their biological effects. These abilities include controlling lung deposition, by adopting formulation strategies or device technologies, and controlling drug uptake and release through sophisticated particle technologies. The large number of contributions to the scientific literature and variety of excellent texts published in recent years is evidence for the continued interest in pulmonary drug delivery research. This reference text endeavors to bring together the fundamental theory and practice of controlled drug delivery to the airways that is unavailable elsewhere. Collating and synthesizing the material in this rapidly evolving field presented a challenge and ultimately a sense of achievement that is hopefully reflected in the content of the volume.
Editors and Affiliations
About the editors
Dr. Hugh Smyth is Assistant Professor of Pharmaceutics at the University of Texas, Austin. He is a recipient of the Young Investigator in Pharmaceutics and Pharmaceutical Technology Award of the American Association of Pharmaceutical Scientists and has edited a volume on pulmonary drug delivery. Drs. Hickey and Smyth share a research interest in the delivery of drugs to the lungs for the treatment and prevention of a number of diseases.
Dr. Anthony Hickey is Professor of Molecular Pharmaceutics and Biomedical Engineering at the University of North Carolina at Chapel Hill. He is a fellow of the Institute of Biology, American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. He has published several edited and authored volumes in the fields of pharmaceutical aerosols, process engineering and particulate science.
Bibliographic Information
Book Title: Controlled Pulmonary Drug Delivery
Editors: Hugh D.C. Smyth, Anthony J. Hickey
Series Title: Advances in Delivery Science and Technology
DOI: https://doi.org/10.1007/978-1-4419-9745-6
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Controlled Release Society 2011
Hardcover ISBN: 978-1-4419-9744-9Published: 01 July 2011
Softcover ISBN: 978-1-4614-2895-4Published: 14 July 2013
eBook ISBN: 978-1-4419-9745-6Published: 24 June 2011
Series ISSN: 2192-6204
Series E-ISSN: 2192-6212
Edition Number: 1
Number of Pages: XIV, 558
Topics: Biomedicine general, Pharmaceutical Sciences/Technology
